Targeted Therapy for Hepatocellular Carcinoma: Co-Delivery of Sorafenib and Curcumin Using Lactosylated pH-Responsive Nanoparticles

PURPOSE: Hepatocellular carcinoma (HCC) is a leading cancer worldwide. In the present investigation, sorafenib (SFN) and curcumin (CCM) were co-delivered using pH-sensitive lactosylated nanoparticles (LAC-NPs) for targeted HCC treatment. METHODS: pH-responsive lactosylated materials were synthesized...

Descripción completa

Detalles Bibliográficos
Autores principales: Bian, Yun, Guo, Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035906/
https://www.ncbi.nlm.nih.gov/pubmed/32109990
http://dx.doi.org/10.2147/DDDT.S238955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035906/
https://www.ncbi.nlm.nih.gov/pubmed/32109990
http://dx.doi.org/10.2147/DDDT.S238955

Ejemplares similares